160 acre biomedical campus gets go ahead in Cambridge, UK
Countryside Properties, Liberty Property Trust and Cambridge University Hospitals NHS Foundation Trust have secured formal planning consent for a 160 acre Cambridge Biomedical Campus development in Cambridge, UK. The Campus will provide 215,000 m2 (2.3 million ft2) of new space for biomedical research, clinical treatment and higher education.
This permission opens the door for Papworth Hospital, the UK’s largest specialist cardio-thoracic hospital, to progress their plans to move to the Campus. The Medical Research Council is already constructing a new 25,000 m2) (270,000 ft2)) Laboratory of Molecular Biology on the site.
The £900m expansion of the Campus by Countryside and Liberty provides an opportunity for specialist occupiers with a biomedical focus, from both the public and private sectors, to relocate to this centre of biomedical excellence at the northern end of the influential biomedical ‘corridor’ between London and Cambridge. It will also be possible for some organisations to co-locate with existing occupiers such as The University of Cambridge School of Clinical Medicine, Cambridge University Hospitals, The Medical Research Council and Cancer Research UK.
The Campus is already home to a number of organisations engaged in discovery science and is associated with 14 Nobel Prize winners, principally working in the world famous MRC Laboratory of Molecular Biology.
The UK Government has selected the Campus as one of only five ‘Comprehensive Biomedical Research Centres’ in the UK. This has secured significant ongoing investment by the National Institute of Health Research in research infrastructure and staffing.
www.cambridge-biomedical.com www.countryside-properties-corporate.com